Daymark Wealth Partners LLC Trims Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Daymark Wealth Partners LLC trimmed its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 97.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,526 shares of the pharmacy operator's stock after selling 119,992 shares during the period. Daymark Wealth Partners LLC's holdings in Walgreens Boots Alliance were worth $39,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in Walgreens Boots Alliance by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after buying an additional 2,279,495 shares during the last quarter. Invesco Ltd. grew its stake in shares of Walgreens Boots Alliance by 8.8% in the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock worth $303,902,000 after acquiring an additional 2,631,332 shares during the last quarter. Geode Capital Management LLC increased its position in Walgreens Boots Alliance by 5.2% during the fourth quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock worth $194,082,000 after acquiring an additional 1,020,587 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock valued at $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. Finally, Northern Trust Corp grew its position in Walgreens Boots Alliance by 18.8% in the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock worth $83,007,000 after purchasing an additional 1,407,973 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Up 0.2%

WBA stock traded up $0.02 during midday trading on Thursday, hitting $11.36. The company had a trading volume of 3,583,868 shares, compared to its average volume of 20,851,778. The stock has a market cap of $9.82 billion, a price-to-earnings ratio of -1.11, a PEG ratio of 1.31 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $16.25. The stock's 50 day moving average price is $11.06 and its 200 day moving average price is $10.63. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period last year, the company earned $1.20 EPS. As a group, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Insider Activity

In other news, Chairman Stefano Pessina acquired 832,258 shares of the firm's stock in a transaction that occurred on Sunday, April 27th. The stock was bought at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the acquisition, the chairman now directly owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. The trade was a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 17.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on WBA. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a "hold" rating for the company. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.